- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02196519
Clinical Evaluation of Cohera Sylys Surgical Sealant as an Adjunct to Standard Bowel Anastomosis Closure
July 18, 2014 updated by: Cohera Medical, Inc.
A first in human study evaluating the safety of Sylys Surgical Sealant in protecting the anastomotic junction created during a stoma reversal procedure.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
16
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Be at least 18 years of age
- Be in good general health in the opinion of the investigator with no conditions that would significantly impact wound healing as determined by medical history and review of recent concomitant medications
- Be scheduled for an ileostomy reversal procedure
- Be willing to follow instructions for incision care
- Agree to return for all follow-up evaluations specified in this protocol
- Sign informed consent
Exclusion Criteria:
- Anesthesia risk judged to be higher than ASA2
- Have severe co-morbid conditions that pose a high risk for surgery and adequate recovery (e.g., heart disease)
- Any condition involving compromised immune system
- Any condition known to effect wound healing, such as collagen vascular disease
- Known blood clotting disorder
- Be receiving antibiotic therapy for pre-existing condition or infection
- Concurrent use of fibrin sealants or other anastomosis care devices
- Be currently taking systemic steroids or immunosuppressive agents
- Have known or suspected allergy or sensitivity to any test materials or reagents
- Be participating in any current clinical trial or have participated in any clinical trial within 30 days of enrollment in this study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Test
All test arm subjects received Sylys Surgical sealant around anastomotic junction after closure.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Number of Adverse Events
Time Frame: 30 days
|
30 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: W Bemelman, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Principal Investigator: E Consten, Meander Medical Center- Amersfoort
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2013
Primary Completion (Actual)
September 1, 2013
Study Completion (Actual)
September 1, 2013
Study Registration Dates
First Submitted
July 17, 2014
First Submitted That Met QC Criteria
July 18, 2014
First Posted (Estimate)
July 22, 2014
Study Record Updates
Last Update Posted (Estimate)
July 22, 2014
Last Update Submitted That Met QC Criteria
July 18, 2014
Last Verified
July 1, 2014
More Information
Terms related to this study
Other Study ID Numbers
- PRO-106-0028
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stoma Reversal Procedure
-
Kantonsspital Winterthur KSWUniversity of Zurich; Zurich University of Applied SciencesCompletedColorectal Surgery | Surgical Operation With Reversal of External StomaSwitzerland
-
St. Louis UniversityEpharmix, Inc.TerminatedComplication of Surgical Procedure | Ileostomy; Complications | Ileostomy - Stoma | Ileostomy Malfunction | Ileostomy UnderactiveUnited States
-
Vascular Solutions LLCWestat; United States Army Medical Materiel Development ActivityNot yet recruitingAnticoagulant ReversalUnited States
-
Charitable Union for the Research and Education...Active, not recruitingVasectomy ReversalUnited States
-
Chang Gung Memorial HospitalConvaTect, TaiwanUnknownStoma Ileostomy | Stoma ColostomyTaiwan
-
Coloplast A/SCompleted
-
Perosphere Pharmaceuticals Inc, a wholly owned...CompletedAnticoagulant Reversal | Reversal of Edoxaban Induced AnticoagulationUnited States
-
Massachusetts General HospitalRecruitingSurgery | Ileostomy - Stoma | Colostomy StomaUnited States
-
BBraun Medical SASRecruitingEnterostomy | Stoma Ileostomy | Stoma ColostomySpain
-
Cukurova UniversityCompletedIncomplete Reversal of Neuromuscular BlockTurkey
Clinical Trials on Sylys Surgical Sealant
-
Cohera Medical, Inc.TerminatedColorectal and Ileorectal Anastomosis | Colocolic and Ileocolic Anastomosis | Coloanal and Ileoanal AnastomosisUnited States
-
Cohera Medical, Inc.TerminatedColorectal and Ileorectal AnastomosisNetherlands
-
Tenaxis Medical, Inc.Completed
-
Sealantis Ltd.Completed
-
University College London HospitalsBaxter BioScienceUnknown
-
The Methodist Hospital Research InstituteTerminatedHeart Failure | Ventricular DysfunctionUnited States
-
C. R. BardCompleted
-
Tenaxis Medical, Inc.CompletedVascular DiseaseUnited States
-
Baxter Healthcare CorporationCompletedBreast Cancer | Lumpectomy | Mastectomy Plus Axillary Lymph Node Dissection | Lymphatic LeakageGermany, Austria, France, Italy
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedLymphedema | Vulvar Cancer | Perioperative/Postoperative ComplicationsUnited States